How Advanced Bioinformatics Can Overcome Data Overwhelm in Biomarker Discovery for Patient Stratification
Identifying biomarkers that predict which patient populations are most likely to respond to a particular treatment can increase the chances of a new investigational drug ultimately entering the market. A robust biomarker strategy is necessary to provide an early indication of whether a drug candidate has the potential to progress, as well as helping drug developers make informed decisions during preclinical and clinical stages.
Download this whitepaper to discover how advanced bioinformatics can help you overcome biomarker discovery challenges via:
